Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 177%
2 regions · 9 outlets · 12 reports — every source grouped by where each outlet is based. Region reflects only headquarters, not the subject of the report.
US
7 articles · 4 outlets
Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 177%
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma
Moderna stock surges as melanoma vaccine trial shows "landmark moment
Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma
Merck and Moderna say melanoma vaccine shows promise
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Other
5 articles · 5 outlets
Personalized mRNA cancer vaccine shows promise in extending life span in melanoma trial
MRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma